The Bank of New York Mellon Corporation BK
Verdict: Sell. Fair value $90.52 against a price of $121 on 5 Jan 2026, 25% below the price.
In plain words
The case for: Wide competitive moat provides durability. Market leadership enables pricing power.
The case against: Operating Cash Flow collapsed to $0.69B in 2024 while Net Income rose to $4.53B. OCF/Net Income.... Significant volatility in cash conversion year-over-year (5.90x in 2022 to 0.15x in 2024)..
Main risks
- Negative Free Cash Flow in 2024 ($-0.78B) despite record Net Income, indicating significant working capital absorption or balance sheet expansion.
- ROIIC of ~7.5% is modest and likely below Cost of Equity, suggesting recent capital deployment has not been highly accretive.
- Revenue growth (4-5% CAGR) is relatively slow, reflecting a mature business model with limited organic expansion upside.
- Operating Cash Flow collapsed to $0.69B in 2024 while Net Income rose to $4.53B. OCF/Net Income...
- Significant volatility in cash conversion year-over-year (5.90x in 2022 to 0.15x in 2024).
- Operating Cash Flow collapsed to $0.69B in 2024 while Net Income rose to $4.53B. OCF/Net Income ratio fell to 0.15.